🟠 Moderate Evidence
The thyroid synthesizes hormones from iodine and the amino acid tyrosine, but a critical third nutrient—selenium—is essential for activating these hormones into their functional form. Without adequate selenium, the body produces inactive T4 hormone but fails to convert it to the active T3 form that cells can use, according to landmark research published in Nature in 1991.
Key takeaways
- Thyroid hormone synthesis requires three nutrients: iodine, tyrosine (from dietary protein), and selenium for activation
- Selenium-dependent enzymes called deiodinases are responsible for converting inactive T4 to active T3 in the liver and kidneys
- Selenium deficiency produces a characteristic pattern of normal T4 with low T3 levels, rendering thyroid hormone biologically inactive
- Iodine supplementation alone is insufficient if selenium status is inadequate
The Three-Nutrient Pathway to Active Thyroid Hormone
Synthesis in the thyroid gland versus activation in peripheral tissues
Source: Berry et al., Nature, 1991; Di Jeso & Arvan, Endocrine Reviews, 2016 | Georgian Medical Journal News
How Selenium Activates Thyroid Hormone
The enzyme responsible for converting inactive T4 to active T3 is called deiodinase, and it cannot function without selenium at its active catalytic site. According to Berry and colleagues in their seminal 1991 Nature publication, this enzyme family requires selenium as a structural component of the selenoprotein that enables the critical T4-to-T3 conversion.
This conversion occurs primarily in peripheral tissues—mainly the liver and kidneys—not in the thyroid gland itself. The distinction is clinically important: patients with adequate iodine intake but insufficient selenium exhibit a distinctive biochemical pattern: normal or elevated T4 levels paired with low T3 levels, rendering the circulating hormone biologically inactive. See more on clinical thyroid management updates.
The Biochemical Pathway: Three Distinct Steps
Thyroid hormone synthesis involves three biochemically distinct stages, each dependent on specific micronutrients. Inside the thyroid, the enzyme thyroperoxidase (TPO) catalyzes the first step: incorporating dietary iodine and the amino acid tyrosine into a storage protein structure.
In the second step, pairs of these iodinated tyrosines fuse together to form T4 (thyroxine), the primary hormone the thyroid releases into the bloodstream. However, T4 itself is metabolically inert—it serves as a precursor hormone awaiting activation elsewhere in the body.
The third and final step—T4 deactivation to T3—depends entirely on selenium. According to Di Jeso and Arvan’s 2016 comprehensive review in Endocrine Reviews, all three deiodinase enzymes (types 1, 2, and 3) contain selenocysteine residues that are essential for catalytic activity. Without adequate selenium, this final conversion simply does not occur, even if upstream synthesis is intact. For evidence-based information on nutrient-thyroid interactions, explore clinical patient guidance on thyroid care.
Selenium-deficient patients present with a characteristic biochemical signature: T4 levels within normal range or elevated, coupled with suppressed T3 levels, despite adequate iodine intake and normal TPO enzyme function. This pattern indicates blocked activation rather than failed synthesis.
— Berry et al., Nature, 1991
Why Tyrosine Rarely Becomes the Limiting Factor
Although tyrosine is structurally incorporated into thyroid hormone, it is synthesized de novo from phenylalanine via normal protein metabolism and is available in adequate quantity from dietary protein in nearly all populations except those experiencing severe protein malnutrition. According to the 2015 Endotext chapter on thyroid hormone synthesis, tyrosine deficiency as a primary cause of thyroid dysfunction is exceptionally rare in clinical practice.
Iodine and selenium, by contrast, are micronutrients with narrow dietary windows and no endogenous synthesis pathway. These are the two nutrients most likely to become limiting factors in thyroid hormone homeostasis, particularly in populations with restricted access to seafood, dairy, or Brazil nuts (selenium) or salt fortification programs (iodine).
What this means
Frequently asked questions
Can selenium supplements replace a healthy diet?
Selenium is best obtained from whole food sources: Brazil nuts (2–3 daily), seafood, poultry, and eggs provide bioavailable selenium in the context of other protective nutrients. Supplemental selenium in excess of the recommended dietary allowance (55 micrograms daily for adults) may increase toxicity risk. The evidence supporting supplementation beyond dietary intake remains weak, so food-first approach is preferred.
Why doesn’t my doctor check T3 if T4 is normal?
Many primary care practices routinely check only TSH and T4 to screen for thyroid disease, as this combination detects overt hypothyroidism in most patients. However, impaired T4-to-T3 conversion—driven by selenium deficiency, chronic illness, caloric restriction, or inflammation—produces a distinct pattern that requires T3 measurement to identify. Requesting both free T3 and free T4 measurements is reasonable if hypothyroid symptoms persist despite normal TSH.
Are there other reasons T4 might not convert to T3 besides selenium deficiency?
Yes. According to the source evidence, caloric restriction, chronic illness, and systemic inflammation all suppress deiodinase activity and reduce T4-to-T3 conversion through separate mechanisms independent of selenium status. Stress hormones, certain medications (beta-blockers, glucocorticoids), and liver disease can also impair conversion. A comprehensive clinical assessment should evaluate these factors alongside micronutrient adequacy.
The traditional focus on iodine supplementation alone has overshadowed the equally critical role of selenium in thyroid hormone bioavailability. As understanding of the complete biochemical pathway matures, nutritional assessment for thyroid disease should expand beyond iodine status to encompass selenium availability and peripheral conversion capacity. Future research should clarify the clinical thresholds at which selenium supplementation becomes necessary in populations at risk, and establish clearer public health guidance on concurrent iodine and selenium adequacy.
Source: Thyroid hormone synthesis pathway: iodine, tyrosine, and selenium
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
